Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jul-Aug;34(6):408-417.
doi: 10.1016/j.nrl.2017.09.008. Epub 2017 Nov 21.

Evidence and experience with onabotulinumtoxinA in chronic migraine: Recommendations for daily clinical practice

[Article in English, Spanish]
A B Gago-Veiga  1 , S Santos-Lasaosa  2 , M L Cuadrado  3 , Á L Guerrero  4 , P Irimia  5 , J M Láinez  6 , R Leira  7 , J Pascual  8 , M Sanchez Del Río  9 , J Viguera  10 , P Pozo-Rosich  11
Affiliations
Free article
Review

Evidence and experience with onabotulinumtoxinA in chronic migraine: Recommendations for daily clinical practice

[Article in English, Spanish]
A B Gago-Veiga et al. Neurologia (Engl Ed). 2019 Jul-Aug.
Free article

Abstract

OnabotulinumtoxinA has been demonstrated to be effective as a preventive treatment in patients with chronic migraine (CM). Five years after the approval of onabotulinumtoxinA in Spain, the Headache Study Group of the Spanish Society of Neurology considered it worthwhile to gather a group of experts in treating patients with CM in order to draw up, based on current evidence and our own experience, a series of guidelines aimed at facilitating the use of the drug in daily clinical practice. For this purpose, we posed 12 questions that we ask ourselves as doctors, and which we are also asked by our patients. Each author responded to one question, and the document was then reviewed by everyone. We hope that this review will constitute a practical tool to help neurologists treating patients with CM.

Keywords: Botulinum neurotoxin A; Chronic migraine; Consenso; Consensus; Guidelines; Migraña crónica; OnabotulinumtoxinA; Preventive treatment; Recomendaciones; Toxina botulínica A; Tratamiento preventivo.

PubMed Disclaimer

Substances